Literature DB >> 16551876

Intraperitoneal immunotherapy for metastatic ovarian carcinoma: Resistance of intratumoral collagen to antibody penetration.

Jaehwa Choi1, Kimberly Credit, Karla Henderson, Ravi Deverkadra, Zhi He, Helge Wiig, Heather Vanpelt, Michael F Flessner.   

Abstract

PURPOSE: Convective transport of macromolecules from the peritoneal cavity into tumor is determined by its hydraulic permeability and the pressure gradient. Previous studies showed that establishing a pressure gradient into the tumor failed to result in significant penetration. This study addresses the hypothesis that the extracellular matrix is the major resistance to the penetration of an i.p. injected antibody. EXPERIMENTAL
DESIGN: Human ovarian tumors (SKOV-3 and OVCAR-3) were established in the abdominal wall of athymic rats. After anesthesia, the tumor serosal surface was treated for 2 hours with Krebs solution (control), collagenase (37.5 unit/mL), or hyaluronidase (10 unit/mL) followed by 3 hours of convective delivery of radiolabeled IgG. Transport of antibody into the tumor was measured with quantitative autoradiography along with the tumor interstitial pressure, concentration of collagen and hyaluronic acid, and IgG volume of distribution.
RESULTS: Antibody was excluded from 42% to 53% of tumor extracellular volume. Exposure of tumors to hyaluronidase did not enhance IgG transport despite removal of 90% of the hyaluronan from the exposed tumor. In contrast, collagenase reduced collagen content, lowered tumor interstitial pressure, and markedly enhanced antibody penetration.
CONCLUSIONS: Reduction of collagen, but not hyaluronan, in the matrix of ovarian xenografts enhanced the transport of i.p. injected antibody. Although high interstitial pressure is a deterrent to convective transport of macromolecules into the tumor parenchyma, the structure of the interstitial matrix provides an inherent resistance, which must be overcome before effective delivery of an antibody.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16551876     DOI: 10.1158/1078-0432.CCR-05-2141

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  38 in total

Review 1.  Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming.

Authors:  Jie Wang; Ze Lu; Yue Gao; M Guillaume Wientjes; Jessie L-S Au
Journal:  Nanomedicine (Lond)       Date:  2011-11       Impact factor: 5.307

2.  Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention.

Authors:  D Scott Wilbur; Ming-Kuan Chyan; Donald K Hamlin; Holly Nguyen; Robert L Vessella
Journal:  Bioconjug Chem       Date:  2011-05-05       Impact factor: 4.774

Review 3.  In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles.

Authors:  Altug Ozcelikkale; Hye-Ran Moon; Michael Linnes; Bumsoo Han
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-14

4.  Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles.

Authors:  Keith B Neeves; Andrew J Sawyer; Conor P Foley; W Mark Saltzman; William L Olbricht
Journal:  Brain Res       Date:  2007-08-29       Impact factor: 3.252

5.  TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma.

Authors:  Jieqiong Liu; Shan Liao; Benjamin Diop-Frimpong; Wei Chen; Shom Goel; Kamila Naxerova; Marek Ancukiewicz; Yves Boucher; Rakesh K Jain; Lei Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-20       Impact factor: 11.205

6.  Semiquantitative assessment of the microdistribution of fluorescence-labeled monoclonal antibody in small peritoneal disseminations of ovarian cancer.

Authors:  Nobuyuki Kosaka; Mikako Ogawa; David S Paik; Chang H Paik; Peter L Choyke; Hisataka Kobayashi
Journal:  Cancer Sci       Date:  2009-10-31       Impact factor: 6.716

7.  Increased nanoparticle penetration in collagenase-treated multicellular spheroids.

Authors:  Thomas T Goodman; Peggy L Olive; Suzie H Pun
Journal:  Int J Nanomedicine       Date:  2007

8.  Interstitial fluid: the overlooked component of the tumor microenvironment?

Authors:  Helge Wiig; Olav Tenstad; Per Ole Iversen; Raghu Kalluri; Rolf Bjerkvig
Journal:  Fibrogenesis Tissue Repair       Date:  2010-07-23

Review 9.  Biological rationale for the design of polymeric anti-cancer nanomedicines.

Authors:  Yan Zhou; Jindřich Kopeček
Journal:  J Drug Target       Date:  2012-09-26       Impact factor: 5.121

Review 10.  Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug Delivery.

Authors:  Aaron Dolor; Francis C Szoka
Journal:  Mol Pharm       Date:  2018-05-16       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.